Position
Fidelity in Dyne Therapeutics, Inc.
Back to the book · All holders of DYN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $36.3M$18.13 → $22.21
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.57M | $128.5M | — | — | — | 0.0% |
| Q1 2026 | 8.91M | $161.5M | $18.13 | −$9.39M | $42.4M | 0.0% |
| Q2 2026 | 11.2M | $248.9M | $22.21 | $36.3M | $51M | 0.0% |